We are live on
!
Find out more
EUCRU
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
EUCRU
Delisted
EUCRU was delisted on the 26th of April, 2023.
19 hedge funds and large institutions have $38.9M invested in Eucrates Biomedical Acquisition Corp. Unit in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
17% less funds holding
Funds holding: 23 → 19 (-4)
24% less capital invested
Capital invested by funds: $50.9M → $38.9M (-$12M)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
19
Holders Change
-4
Holders Change %
-17.39%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$112K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$46.8K |
